Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors (TALENT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02678780
Recruitment Status : Completed
First Posted : February 10, 2016
Last Update Posted : January 17, 2018
Sponsor:
Collaborators:
Eisai Limited
Experior S.L.
Information provided by (Responsible Party):
Grupo Espanol de Tumores Neuroendocrinos

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2017
Study Completion Date : No date given